Evaluating the anti-tumor and anti-hyperlipidemic effects of Apium graveolens (celery) extracts
11/25/2020 // Evangelyn Rodriguez // Views

Researchers from India explored the antihyperlipidemic and anti-tumor properties of the ethanolic extract and phytochemicals derived from Apium graveolens, commonly known as celery, in rodents. They reported their findings in an article published in the Journal of Dietary Supplements.

  • Chromatographic analysis of the seeds of A. graveolens shows that they contain coumarin derivatives like seselin, methoxsalen and 3H-isobenzofuran-1-one.
  • To further explore their biological properties, the researchers first induced hyperlipidemia in rats by injecting them with 400 mg/kg body weight of Triton WR 1339.
  • After 24 hours, they orally administered the A. graveolens extract and isolated components to the animals at a dose of 50 mg/kg body weight.
  • They also evaluated the anti-tumor activity of the extract and isolated phytochemicals by injecting hybrid mice with 50 mg/kg body weight of either sample for 10 consecutive days.
  • They then observed the animals for tumor growth after injecting B16F10 melanoma cells into their dorsal skin.
  • The researchers found that the A. graveolens extract and isolated components significantly decreased total cholesterol, triglycerides and low-density lipoprotein (LDL) while increasing high-density lipoprotein (HDL) levels in hyperlipidemic rats.
  • Pretreatment of the extract and isolated compounds also delayed tumor growth in hybrid mice by increasing volume-doubling time and mean survival time.
  • In addition, tumor regression studies showed a decrease in tumor growth of the injected melanoma cells in vivo.

Based on these findings, the researchers concluded that A. graveolens is an excellent source of natural antihyperlipidemic and anti-tumor agents.

Journal Reference:

Iyer D, Patil UK. ASSESSMENT OF ANTIHYPERLIPIDEMIC AND ANTITUMOR EFFECT OF ISOLATED ACTIVE PHYTOCONSTITUENTS FROM APIUM GRAVEOLENS L. THROUGH BIOASSAY-GUIDED PROCEDURES. Journal of Dietary Supplements. 06 April 2018;16(2):193–206. DOI: 10.1080/19390211.2018.1448921



Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NaturalNews.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.